BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15794306)

  • 21. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations for prevention of roentgen contrast medium-induced nephropathy].
    Möckel M; Bahr F; Leuner Ch; Kuhn H; Dietz R
    Z Kardiol; 2002 Sep; 91(9):719-26. PubMed ID: 12448072
    [No Abstract]   [Full Text] [Related]  

  • 23. N-acetylcysteine to prevent contrast nephropathy.
    Meine TJ; Washam JB
    Am Heart J; 2004 Mar; 147(3):440-1. PubMed ID: 14999191
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
    Meschi M; Detrenis S; Savazzi G
    Recenti Prog Med; 2008 Mar; 99(3):155-62. PubMed ID: 18488528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to prevent contrast nephropathy.
    Oudemans-van Straaten HM
    Minerva Cardioangiol; 2005 Oct; 53(5):445-63. PubMed ID: 16179886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine for contrast nephropathy: more clinical science is required.
    Eddleston M; Goddard J; Bateman N
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
    [No Abstract]   [Full Text] [Related]  

  • 27. Can we prevent acute kidney injury?
    Venkataraman R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of contrast induced nephropathy--an update.
    Gupta S; Gupta BM
    Indian Heart J; 2007; 59(4):375-7. PubMed ID: 19126948
    [No Abstract]   [Full Text] [Related]  

  • 29. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiologic contrast-induced renal failure.
    Fontanarosa PB
    Emerg Med Clin North Am; 1988 Aug; 6(3):601-16. PubMed ID: 3292229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal failure after enhanced computed tomography.
    Gordon S; Barnes SJ
    Arch Intern Med; 1983 May; 143(5):1042-3. PubMed ID: 6679217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
    Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
    Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
    Asher I; Hammerman A; Sthoeger Z
    Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low fractional excretion of sodium with contrast media-induced acute renal failure.
    Fang LS; Sirota RA; Ebert TH; Lichtenstein NS
    Arch Intern Med; 1980 Apr; 140(4):531-3. PubMed ID: 7362385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
    Shavit L; Lifschitz M; Lachish T; Rosenmann D; Balkin J; Slotki I
    Harefuah; 2007 Sep; 146(9):655-9, 736. PubMed ID: 17969299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney.
    Heyman SN; Rosen S; Brezis M
    Exp Nephrol; 1994; 2(3):153-7. PubMed ID: 7922266
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology of contrast-induced nephropathy].
    Guastoni C; De Servi S
    G Ital Cardiol (Rome); 2009 Feb; 10(2):73-8. PubMed ID: 19348143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.